Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
SOLES Act
Client: FOUNDATION HEALTH PARTNERS · Firm: HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
H.R.4250/S.553, Save our Lone Emergency Services Act (SOLES Act) Issues relating to healthcare, including Medicare/Medicaid
Medicaid Financing Clarification Act of 2026
Client: NEW LIGHT HEALTHCARE · Firm: HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
H.R.9139, Medicaid Financing Clarification Act of 2026 Issues relating to healthcare, including Medicare/Medicaid
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2026 · third_quarter · Q3
H.R.9139, Medicaid Financing Clarification Act of 2026 Issues relating to healthcare, including Medicare/Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2026 · third_quarter · Q3
Source: Senate LDA
SOLES Act
Client: FOUNDATION HEALTH PARTNERS · Firm: HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
H.R.4250/S.553, Save our Lone Emergency Services Act (SOLES Act) Issues relating to healthcare, including Medicare/Medicaid
H.R.4250/S.553, Save our Lone Emergency Services Act (SOLES Act) Issues relating to healthcare, including Medicare/Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2026 · second_quarter · Q2
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2026 · second_quarter · Q2
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2026 · first_quarter · Q1
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2026 · first_quarter · Q1
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · fourth_quarter · Q4
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · fourth_quarter · Q4
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · third_quarter · Q3
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · third_quarter · Q3
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
STONINGTON GLOBAL LLC ON BEHALF OF TL MANAGEMENT LLC via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · third_quarter · 3T
issues relating to healthcare
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · second_quarter · Q2
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · second_quarter · Q2
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
STONINGTON GLOBAL LLC ON BEHALF OF TL MANAGEMENT LLC via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · second_quarter · Q2
issues relating to healthcare
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · first_quarter · Q1
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · first_quarter · Q1
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
STONINGTON GLOBAL LLC ON BEHALF OF TL MANAGEMENT LLC via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · first_quarter · Q1
issues relating to healthcare
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
STONINGTON GLOBAL LLC ON BEHALF OF TL MANAGEMENT LLC via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2025 · first_quarter · RA
Issues relating to skilled nursing homes.
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2024 · fourth_quarter · Q4
issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2024 · fourth_quarter · Q4
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2024 · third_quarter · Q3
issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2024 · third_quarter · Q3
Issues relating to healthcare.
Filing targets: HOUSE OF REPRESENTATIVES
FOUNDATION HEALTH PARTNERS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2024 · third_quarter · RR
issues relating to healthcare
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2022 · third_quarter · Q3
issues relating to heathcare access
Filing targets: HOUSE OF REPRESENTATIVES
MD HEALTH PATHWAYS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2022 · third_quarter · RR
issues related to healthcare access
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2022 · third_quarter · RR
issues relating to healthcare access
NEW LIGHT HEALTHCARE via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2022 · third_quarter · RR
issues relating to healthcare access
STONINGTON GLOBAL LLC ON BEHALF OF TL MANAGEMENT LLC via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · third_quarter · 3T
1. Federal civil liability protection in regards to coronavirus for skilled nursing homes. 2. Work to ensure priority access to PPE, rapid testing, and stronger guidance to states on new regulations.
STONINGTON GLOBAL LLC ON BEHALF OF NOSTRUM PHARMACEUTICALS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · third_quarter · 3T
1. Request to CMS/Medicaid to review drug rebate rule in regards to and AMP re-adjustment for Nitrofuratonin OS. 2. Request to CMS to appeal baseline AMP for Nitrofuratonin OS.
Filing targets: White House Office
STONINGTON GLOBAL LLC ON BEHALF OF SMART METER via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · third_quarter · 3T
1. FDA waiver and/or emergency use authorization for glucose meters to be used in long-term care facilities during the coronavirus pandemic. 2. Petition FDA to update FAQs on at-home-use glucose meters for hospital use during the coronavirus pandemic to include long-term care facilities.
Filing targets: Food & Drug Administration (FDA)
STONINGTON GLOBAL LLC ON BEHALF OF TL MANAGEMENT LLC via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · second_quarter · Q2
1. Federal civil liability protection in regards to coronavirus for skilled nursing homes. 2. Work to ensure priority access to PPE, rapid testing, and stronger guidance to states on new regulations. 3. Next steps for Phase 4 funding for skilled nursing facilities.
Filing targets: Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), White House Office
STONINGTON GLOBAL LLC ON BEHALF OF NOSTRUM PHARMACEUTICALS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · second_quarter · Q2
1. Request to CMS/Medicaid to review drug rebate rule in regards to and AMP re-adjustment for Nitrofuratonin OS. 2. Request to CMS to appeal baseline AMP for Nitrofuratonin OS.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Health & Human Services, Dept of (HHS)
STONINGTON GLOBAL LLC ON BEHALF OF SMART METER via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · second_quarter · Q2
1. FDA waiver and/or emergency use authorization for glucose meters to be used in long-term care facilities during the coronavirus pandemic. 2. Petition FDA to update FAQs on at-home-use glucose meters for hospital use during the coronavirus pandemic to include long-term care facilities.
Filing targets: Food & Drug Administration (FDA)
STONINGTON GLOBAL LLC ON BEHALF OF TL MANAGEMENT LLC via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · second_quarter · RR
COVID-19 related funding issues for skilled nursing homes; liability protection for skilled nursing homes; allocation for testing & PPE for skilled nursing homes
COVID-19 related funding issues for skilled nursing homes; liability protection for skilled nursing homes; allocation for testing & PPE for skilled nursing homes
COVID-19 related funding issues for skilled nursing homes; liability protection for skilled nursing homes; allocation for testing & PPE for skilled nursing homes
STONINGTON GLOBAL LLC ON BEHALF OF NOSTRUM PHARMACEUTICALS via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · second_quarter · RR
CMS Medicaid rebate & drug pricing for Nitrofuratonin OS
STONINGTON GLOBAL LLC ON BEHALF OF SMART METER via HARGAN STRATEGIES, FORMERLY REPORTED AS HARGAN AND ASSOCIATES
2020 · second_quarter · RR
FDA Authorization to use Smart Meter's iGlucose monitor in nursing home facilities during COVID-19.